Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Encuragen logo — Pioneering biological therapeutics to cure difficult disease...

Encuragen

Pioneering biological therapeutics to cure difficult diseases and enhance human health through innovative research and synthetic biology advancements.

Founded 2016 Venture round Biotechnology, Health and Wellness +1

General Information

Company Name Encuragen
Founded Year 2016
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Encuragen. To contact Encuragen, visit encuragen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Encuragen compare?

A PDF of Encuragen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Encuragen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Encuragen

Encuragen is a biotechnology startup founded in 2016 which has been making waves in the industry. The company's slogan, "Pioneering biological therapeutics to cure difficult diseases and enhance human health through innovative research and synthetic biology advancements," encapsulates its bold mission to revolutionize healthcare. Encuragen is distinguished by its dedication to pioneering biological therapeutics aimed at curing incurable diseases and enhancing human health. Unlike traditional approaches, the company's focus on fundamental cures for challenging conditions sets it apart. Encuragen aims to offer comprehensive therapeutic solutions through innovative medicines. Furthermore, the company specializes in synthetic biology, expanding opportunities for emerging industries through the application of foundational life sciences. Notably, their recent Venture Round investment at 01 March 2021 from STIC Ventures underscores investor confidence in their pioneering work. With its visionary approach and commitment to groundbreaking scientific research, Encuragen represents a promising investment opportunity in the biotechnology and pharmaceutical sectors.

Business keywords: biological therapeutics, innovative research, synthetic biology, disease cure, human health, scientific research, fundamental cures, novel medicines, R&D, synthetic biology, life sciences, pharmaceuticals, medical research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
STIC Ventures
01 Mar 2021
Venture Round Undisclosed 1
Intops Investment
Intops Investment
01 Jan 2020

Encuragen Alternatives & Competitors

View All Alternatives
Encuragen vs
GRO Biosciences
GRO Biosciences United States

GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein...

Series B
32 employees
Biotechnology, Health Care
Encuragen vs
PROGEN
PROGEN Germany

Making life sciences better. Together.

41 employees
Biotechnology, Health and Wellness
Encuragen vs
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. United States

Pioneering innovative therapies for rare diseases, dedicated to enhancing patient quality of life.

55 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Encuragen

Pioneering biological therapeutics to cure difficult diseases and enhance human health through innovative research and synthetic biology advancements.
Encuragen was founded in 2016.
Encuragen operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biological therapeutics, innovative research, synthetic biology and disease cure.
Encuragen has completed 2 funding rounds. The latest funding stage is Venture round.
Top alternatives and competitors to Encuragen include GRO Biosciences, PROGEN, Leadiant Biosciences, Inc., Booster Therapeutics, Q Chip Ltd - Now Midatech Pharma (Wales) Limited and part of Midatech Pharma plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Encuragen and GRO Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Encuragen, https://bouncewatch.com/company/encuragen, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes